Nachrichten zur Johnson & Johnson Aktie

Johnson & Johnson stock rises Wednesday, still underperforms market

Johnson & Johnson stock rises Wednesday, still underperforms market...…

Begrenzter Rechtsschutz für Corona-Impfstoffhersteller bremst Deals mit der EU

Brüssel (Reuters) - Die Europäische Union bietet den Corona-Impfstoffentwicklern Insidern zufolge nur einen teilweisen Schutz vor rechtlichen Risiken im Zusammenhang…

Johnson & Johnson: Accelerating Their Virus Vaccine Development And The Buy Of Momenta With Debt Is A Good Move

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

JOHNSON & JOHNSON: 8-K Report

8-K...…

Johnson & Johnson stock falls Tuesday, underperforms market

Johnson & Johnson stock falls Tuesday, underperforms market...…

Top Stock Reports for JNJ, Procter & Gamble & Thermo Fisher

Top Stock Reports for JNJ, Procter & Gamble & Thermo Fisher...…

Johnson & Johnson stock rises Monday, still underperforms market

Johnson & Johnson stock rises Monday, still underperforms market...…

EU will sich auch Corona-Impfstoff von Moderna sichern

BRÜSSEL (dpa-AFX) - Die EU hat mit einem weiteren Unternehmen Vorgespräche über den Erwerb eines möglichen…

XETR : INSTRUMENT_EVENT JNJ

DIVIDEND/INTEREST INFORMATION - 24.08.2020;Das Instrument JNJ US4781601046 JOHNSON + JOHNSON DL 1 EQUITY wird ex Dividende/Zinsen…

Johnson & Johnson stock rises Friday, outperforms market

Johnson & Johnson stock rises Friday, outperforms market...…

Pharma Stock Roundup: SNY, JNJ Acquisition Deals, FDA Approvals

J&J (JNJ) proposes to buy Momenta Pharmaceuticals while Sanofi (SNY) offers to buy Principia Biopharma...…

New bond issue: Johnson&Johnson issued international bonds (US478160CT90) with a 2.45% coupon for USD 1,250.0m maturing in 2060

August 20, 2020 Johnson&Johnson issued international bonds (US478160CT90) with a 2.45% for USD 1,250.0m maturing in 2060. Bonds were sold…

New bond issue: Johnson&Johnson issued international bonds (US478160CS18) with a 2.25% coupon for USD 1,000.0m maturing in 2050

August 20, 2020 Johnson&Johnson issued international bonds (US478160CS18) with a 2.25% for USD 1,000.0m maturing in 2050. Bonds were sold…

New bond issue: Johnson&Johnson issued international bonds (US478160CQ51) with a 1.3% coupon for USD 1,750.0m maturing in 2030

August 20, 2020 Johnson&Johnson issued international bonds (US478160CQ51) with a 1.3% for USD 1,750.0m maturing in 2030. Bonds were sold…

New bond issue: Johnson&Johnson issued international bonds (US478160CP78) with a 0.95% coupon for USD 1,500.0m maturing in 2027

August 20, 2020 Johnson&Johnson issued international bonds (US478160CP78) with a 0.95% for USD 1,500.0m maturing in 2027. Bonds were sold…

New bond issue: Johnson&Johnson issued international bonds (US478160CR35) with a 2.1% coupon for USD 1,000.0m maturing in 2040

August 20, 2020 Johnson&Johnson issued international bonds (US478160CR35) with a 2.1% for USD 1,000.0m maturing in 2040. Bonds were sold…

New bond issue: Johnson&Johnson issued international bonds (US478160CN21) with a 0.55% coupon for USD 1,000.0m maturing in 2025

August 20, 2020 Johnson&Johnson issued international bonds (US478160CN21) with a 0.55% for USD 1,000.0m maturing in 2025. Bonds were sold…

Fresenius vs. J&J: Eindeutig, der DAX-Dividendenaristokrat ist jetzt viel attraktiver!

Fresenius und Johnson & Johnson besitzen einige Gemeinsamkeiten. Die Unterschiede offenbaren jetzt jedoch, wie günstig die DAX-Aktie ist. The post Fresenius…

J&J Plans Pivotal Trial for Covid-19 Vaccine

Johnson & Johnson plans to start a late-stage trial for the companys Covid-19 vaccine in late September, and aims to…

DIVIDEND/INTEREST INFORMATION - 24.08.2020 - 1

FOLGENDE WERTPAPIERE WERDEN AM 21.08.2020 CUM DIVIDENDE/ZINSEN UND AM 24.08.2020 EX DIVIDENDE/ZINSEN GEHANDELT. THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL…

Johnson & Johnson draws cheap pricing in $7.5B bond offering for Momenta purchase

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson Borrows $7.5B To Fund Its Purchase Of Momenta

Johnson & Johnson (NYSE: JNJ) is borrowing $7.5 billion in bonds to help fund its purchase of Momenta Pharmaceuticals, Inc…

Johnson & Johnson adds to debt frenzy, borrows $7.5 billion to buy Momenta

J&J is seizing on cheap pandemic funding available in the booming U.S. corporate bond market to raise enough money to…

Johnson & Johnson to launch late-stage coronavirus vaccine trials in September

The company aims to recruit 60,000 participants for the study. The post Johnson & Johnson to launch late-stage coronavirus vaccine trials…

Johnson & Johnson: An Update Following The Momenta Deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J Plans Huge Vaccine Study While Pfizer Cites Rapid Enrollment

J&J Plans Huge Vaccine Study While Pfizer Cites Rapid Enrollment...…

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Momenta Pharmaceuticals, Inc. to Johnson & Johnson

New York, New York--(Newsfile Corp. - August 20, 2020) - The following statement is being issued by Levi &…

Johnson & Johnson stock rises Thursday, outperforms market

Johnson & Johnson stock rises Thursday, outperforms market...…

Johnson & Johnson Sets Late-Stage Vaccine Trial Next Month

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Große Impfstoffstudie von J&J in Aussicht

Große Impfstoffstudie von J&J in Aussicht...…

ETFs in Focus on Momenta Buyout Deal With JNJ

A number of ETFs could be the best ways for investors to tap the opportunity arising from the Momenta buyout…

J&J planning 60K-subject study to test COVID-19 vaccine

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J to Buy Momenta for $6.5B to Boost Autoimmune Presence

J&J (JNJ) offers to buy Momenta, which focuses on the development of novel drugs to treat rare, immune-mediated disorders....…

Company News for Aug 20, 2020

Companies In The News Are: MNTA, JNJ, TGT, REGN, GLPG, GILD....…

Momenta Surges on Acquisition Deal With Johnson & Johnson

Momenta (MNTA) soars on the announcement of being acquired by Johnson & Johnson for $6.5 billion....…

J&J files for debt offering to fund Momenta buy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative

NEW BRUNSWICK, N.J. , Aug. 20, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE:…